Articles written by: Eric Painter

Pacific Premier Bancorp Inc Big Money Sentiment  Crashed in  Q2 2018 touching 1.37

Pacific Premier Bancorp Inc Big Money Sentiment Crashed in Q2 2018 touching 1.37

“Big money” Positions In Q2 2018 Pacific Premier Bancorp Inc (NASDAQ:PPBI) big money sentiment decreased to 1.37, according to SEC.gov filings. That’s down -0.12, from 2018Q1’s 1.49. 89 active investment managers increased and started new positions, while 65 trimmed and sold equity positions in Pacific Premier Bancorp Inc so the […]

EPS for BRT Apartments Corp. (BRT) Expected At $0.20 as of December, 13

EPS for BRT Apartments Corp. (BRT) Expected At $0.20 as of December, 13

During Q2 2018 the big money sentiment increased to 4.67. That’s change of 0.17, from 2018Q1’s 4.5. 3 investors sold all, 6 reduced holdings as BRT Apartments Corp. ratio increased. 17 grew positions while 25 funds bought positions. Funds hold 8.80 million shares thus 32.42% more from 2018Q1’s 6.65 million […]

TAG Heuer Connected Has Production Increase Due to Demand

TAG Heuer Connected Has Production Increase Due to Demand

One month ago, when TAG Heuer Connected was first launched, there were some people wondering if there was a market for a luxury Android smartwatch that cost $1,500. Apparently, the answer is yes since TAG Heuer said it must increase its production for the watch to meet its demands.

On Dec 8, 2018 Telsey Advisory Group Reaffirms Stock Outperform Rating on G-III Apparel (NASDAQ:GIII) and $47 Target.

On Dec 8, 2018 Telsey Advisory Group Reaffirms Stock Outperform Rating on G-III Apparel (NASDAQ:GIII) and $47 Target.

Big Money Sentiment increased to 2.18 in 2018 Q2. It has change of 0.94, from 2018Q1’s 1.24. The ratio increased due to G-III Apparel Group, Ltd. positioning: 10 sold and 47 reduced. 58 funds amassed stakes and 66 increased stakes. Investors holded 45.68 million in 2018Q1 but now own 47.13 […]

Merck Does Not Gain Backing from FDA Panel for Vytorin

Merck Does Not Gain Backing from FDA Panel for Vytorin

Merck & Co should not be given the ok to claim Vytorin, its drug for lowering cholesterol, reduces the risk of strokes or heart attack in patients that have coronary heart disease, said an advisory committee on Monday to the United States Food and Drug Administration. The advisory panel evaluated […]